April 2015 FDA Recall Drug by Cipla Limited
D-1078-2015 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Cipla Limited on April 24, 2015 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1078-2015

Reason for Recall
Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.
Initiated
04-24-2015
Reported
05-20-2015
Quantity
140,625 Vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
U.S. Nationwide including Puerto Rico.
Levalbuterol Inhalation Solution, USP, 0.31 mg/ 3 mL, 3 mL Vials, Rx Only. Manufactured by: Cipla Ltd. Plot 9 & 10, Indure, SEZ, Pithampur, M.P.-454 775, INDIA, Manufactured for: Dr. Reddy's Laboratories, Inc., Princeton NJ 08640. NDC: 43598-412-25.

Batch or Lot Expiration Information

Lot# : FA4022; Expiry: December 2015.